BACKGROUND Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia, considered a variant of lichen planopilaris due to histological similarities.1 Clinically, FFA causes gradual hair loss of the frontotemporal…
Read More
Microneedling is a minimally invasive procedure for treating acne scars which has already been well-established, but it has been reborn in recent years because of innovative findings. It presents many…
Read More
INTRODUCTIONFemale pattern hair loss (FPHL) results from a combination of hormones, aging, and genetics, and is the most common type of alopecia in women. Topical minoxidil remains the only United…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively impacts quality of life.1-6 Conventional HS therapies are variably effective,2 and patients often turn to complementary and alternative…
Read More
INTRODUCTIONMastocytosis describes a group of disorders with a pathologic accumulation of mast cells in various tissues. Urticaria pigmentosa is mastocytosis of the skin, which manifests as mastocytomas that can produce…
Read More
INTRODUCTIONUnderstanding Exosome Therapy Exosome therapy represents a cutting-edge approach in regenerative medicine, leveraging the potential of exosomes derived from optimal cellular environments to achieve specific therapeutic effects in target areas.…
Read More
INTRODUCTIONTopical ruxolitinib is a potent Janus kinase (JAK) inhibitor that has demonstrated significant efficacy in treating an array of inflammatory skin conditions. While topical ruxolitinib has been most extensively studied…
Read More
INTRODUCTIONPemphigus vulgaris (PV) refers to a group of autoimmune, blistering diseases that results in lesions affecting predominantly the mucosa and skin. Autoantibodies (anti-Dsg1 and anti-Dsg3) target desmogleins (Dsg1 and Dsg3),…
Read More
INTRODUCTIONPemphigus is a rare autoimmune blistering disease that is associated with significant morbidity and mortality. Rituximab demonstrated superiority over oral steroid monotherapy and steroid-sparing agent mycophenolate in prior clinical trials…
Read More
INTRODUCTIONAndrogenetic alopecia (AGA) results in progressive hair loss due to miniaturization of hair follicles secondary to androgen influence.1 AGA affects both men and women and is a common dermatologic complaint…
Read More
INTRODUCTIONCompounding pharmacies are pharmacies that can prepare unique formulations of topical medications, modify existing formulations of drugs, and create a variety of off-label formulations specific to a patient's needs. These…
Read More
INTRODUCTIONTopical minoxidil (TM) has been widely used to treat various hair loss conditions since it was first approved in the United States in 1986.1 More recently, low dose oral minoxidil…
Read More
